| Literature DB >> 27013135 |
Kristof Zarschler1, Louise Rocks2, Nadia Licciardello3, Luca Boselli2, Ester Polo2, Karina Pombo Garcia4, Luisa De Cola5, Holger Stephan4, Kenneth A Dawson2.
Abstract
Ultrasmall nanoparticulate materials with core sizes in the 1-3nm range bridge the gap between single molecules and classical, larger-sized nanomaterials, not only in terms of spatial dimension, but also as regards physicochemical and pharmacokinetic properties. Due to these unique properties, ultrasmall nanoparticles appear to be promising materials for nanomedicinal applications. This review overviews the different synthetic methods of inorganic ultrasmall nanoparticles as well as their properties, characterization, surface modification and toxicity. We moreover summarize the current state of knowledge regarding pharmacokinetics, biodistribution and targeting of nanoscale materials. Aside from addressing the issue of biomolecular corona formation and elaborating on the interactions of ultrasmall nanoparticles with individual cells, we discuss the potential diagnostic, therapeutic and theranostic applications of ultrasmall nanoparticles in the emerging field of nanomedicine in the final part of this review.Entities:
Keywords: Active targeting; Cancer; Nanomedicine; Pharmacokinetics; Protein corona; Renal excretion; Ultrasmall nanoparticles
Mesh:
Year: 2016 PMID: 27013135 DOI: 10.1016/j.nano.2016.02.019
Source DB: PubMed Journal: Nanomedicine ISSN: 1549-9634 Impact factor: 5.307